Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00729131 · ClinicalTrials.gov registry record
Functional Implications of TNF
A clinical trial of Bronchitis, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT00729131 is a study of Bronchitis that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00729131, a study of Bronchitis, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The research plan proposes to develop translational studies in humans that will identify host susceptibility factors that confer vulnerability to the prototypal air pollutant, ozone. Ozone is a ubiquitous urban air pollutant and associated with increased emergency room visits, and co-associates with other air pollutants, to increase mortality in high risk groups (cardio-pulmonary disease) of the population.The results will have significant impact upon and aid in understanding mechanisms of pro-oxidant lung injury, airway hyperresponsiveness, and adverse health effects, that occur during and following exposure to inhalable airborne irritants.
Conditions Studied
Interventions
- DRUG Etanercept inhibition of ozone-induced airway hyper-responsiveness.
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-08 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00729131
The ClinicalTrials.gov registry entry for NCT00729131 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Environmental Health Sciences (NIEHS), which has 145 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bronchitis appearing as the primary indexed condition, and to 1 intervention - of which Etanercept inhibition of ozone-induced airway hyper-responsiveness. is the first listed.
NCT00729131 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00729131 about?
NCT00729131 is a clinical study titled "Functional Implications of TNF". The research plan proposes to develop translational studies in humans that will identify host susceptibility factors that confer vulnerability to the prototypal air pollutant, ozone. Ozone is a ubiquitous urban air pollutant and associated with increased emergency room visits, and co-associates with...
What is the current status of trial NCT00729131?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2008-08. Estimated completion is 2012-02.
What conditions does trial NCT00729131 study?
This clinical trial studies the following conditions: Bronchitis.
What interventions are being tested in trial NCT00729131?
The interventions under investigation include: Etanercept inhibition of ozone-induced airway hyper-responsiveness. (DRUG).
Who is sponsoring clinical trial NCT00729131?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00729131 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.